LAKE OSWEGO, Ore., July 8, 2019 /PRNewswire/ -- BIOTRONIK today announced FDA clearance of the BIOMONITOR III injectable cardiac monitor (ICM). BIOMONITOR III is designed to docume

CHICAGO, July 8, 2019 /PRNewswire/ -- Flexpoint Ford, LLC, a private equity investment firm specializing in the financial services and healthcare industries, announced today the first and final closing of its fourth private equity fund, Flexpoint Fund IV, L.P. ("Fund IV"), along with a companion fund, Flexpoint Overage Fund IV, L.P. ("Overage Fund IV"). Total c

SAN DIEGO, July 8, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against CannTrust Holdings Inc. ("CannTrust") (NYSE: CTST) for violations of federal securities laws. CannTrust produces and distributes medical and recreational cannabis in Canada.On

CHICAGO, July 8, 2019 /PRNewswire/ -- Kalderos Director of Industry Relations Steve Zielinski will address the significance of duplicate discounts and how Kalderos' da

TARRYTOWN, N.Y., July 8, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2019 financial and operating results on Tuesday, August 6, 2019, before the U.S. financial markets open.  The Company will host a conference call and simultaneous webca

IRVINE, Calif., July 8, 2019 /PRNewswire/ -- AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today new clinical data from its ongoing glioblastoma Phase 2 clinical trial, investigating AIVITA's platform immunotherapy targeting cancer stem cells. Blood plasma biomarker analyses have identified predictive markers of e

HOD HASHARON, Israel, July 8, 2019 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, announced today that it has retained Lighthouse BioPartners, LLC a US-based firm specialized in partnering and financial adv

WATERTOWN, Mass., July 8, 2019 /PRNewswire/ -- EyePoint Pharmaceuticals, Inc., a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, commercially launched DEXYCU® (dexamethasone intraocular suspension) 9% in March 2019 in the United States

--- Shipments to commence immediately from the Company's Mississauga, Ontario facility TORONTO, July 8, 2019 /PRNewswire/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company") today announced that its subsidiary, TerrAscend Canada, has received an amendment to its license from H

PLYMOUTH MEETING, Pa., July 8, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it has completed enrollment in its Phase 2 trial with VGX-3100 in patients with precancerous lesions of the vulva or vulvar intraepithelial neoplasia (VIN). VGX-3100 is an immunotherapy that targets human papillomavirus (HPV) 16 and 18 and is being stud